Australia's most generous blood plasma donor dies aged 88
MELBOURNE, Australia — An Australian man credited with saving 2.4 million babies through his record-breaking blood plasma donations over six decades, has died aged 88, his family said on Tuesday.
James Harrison, a retired state railway department clerk, died in a nursing home where he had lived for five weeks on the Central Coast of New South Wales state on Feb. 17, according to his grandson, Jarrod Mellowship.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
3 hours ago
- Time Business News
Health Department Awards Optus $33M Contract for Medicare Communications Infrastructure
The Department of Health has awarded Australian telecommunications giant Optus a $33 million contract to provide critical communications services underpinning Australia's Medicare and e-health systems, marking a significant vote of confidence in the carrier following recent cybersecurity challenges. The three-year deal, with potential extension to six years, was confirmed through a contract notification posted on the government's AusTender procurement website. The agreement consolidates Optus's position as a strategic telecommunications provider to the federal government. Under the arrangement, Optus will deliver what the company describes as 'a fully managed Network-as-a-Service (NaaS) solution for the Department of Health, Disability and Ageing, supporting its digital transformation.' The contract represents a consolidation of various telecommunications services previously spread across multiple arrangements. Optus has historically maintained substantial portions of the Health Department's carrier contracts, but the new deal brings together disparate services under a unified framework. The award comes as the Albanese government prioritizes securing core digital infrastructure supporting Medicare and broader e-health services. The telecommunications backbone provided under the contract will underpin the delivery of essential health services to millions of Australians. The deal also signals renewed government confidence in Optus following a turbulent period for the carrier. The company was among several major Australian corporations targeted by Russian-linked ransomware attacks, drawing criticism from former Home Affairs Minister Clare O'Neil. The cyberattacks resulted in the application of sanctions following what officials described as malicious raids on critical infrastructure providers. Despite these security challenges, the Health Department's decision to award the substantial contract to Optus suggests the government views the carrier as having adequately addressed previous vulnerabilities. The Network-as-a-Service model allows the Health Department to access telecommunications infrastructure without the need for significant capital investment in physical network equipment, while ensuring reliable connectivity for critical health system operations. The contract timeline provides flexibility for both parties, with the initial three-year term allowing for performance evaluation before potential extension to the full six-year period. This structure enables the government to maintain service continuity while preserving options for future procurement decisions. TIME BUSINESS NEWS
Time Business News
6 hours ago
- Time Business News
Mitesh Patel and Newarc Edge: Transforming Healthcare Construction Across Australia
Sydney, Australia – With a strong foundation in business and healthcare, Mitesh Patel has played a pivotal role in shaping the landscape of medical facility construction in Australia. His journey, from studying business in Singapore in 2001 to furthering his education in Switzerland & Sydney, laid the groundwork for his expertise in healthcare infrastructure. After gaining over a decade of experience at Dentsply Sirona, Mitesh entered the healthcare industry in 2008, quickly earning a reputation for excellence. In partnership with Josh Gaddes, Mitesh co-founded Newarc Edge, a company dedicated to delivering high-quality medical and dental fitouts. Their commitment to precision and innovation has made them a preferred choice among Australian doctors, leading to multiple industry awards and widespread recognition. Newarc has successfully completed healthcare construction projects values in the multiple millions of dollars, reinforcing its position as a trusted leader in the Australian healthcare industry. Expanding Healthcare Infrastructure Nationwide Newarc Edge has successfully completed over 750 healthcare suites across Australia, specializing in dental clinics, medical practices, surgeon suites, hospitals, and commercial healthcare buildings. Their expertise in ergonomic design, workflow optimization, and compliance with healthcare regulations ensures that each facility is tailored to the unique needs of practitioners and patients. Recent standout projects include: Nepean Hospital ENT Suite – A state-of-the-art facility designed for leading ENT specialists, integrating advanced medical technology and patient-centered design. – A state-of-the-art facility designed for leading ENT specialists, integrating advanced medical technology and patient-centered design. Dr. Jeremy's Dental Practice in Ryde – A sophisticated dental practice built with cutting-edge equipment and optimized for efficiency. – A sophisticated dental practice built with cutting-edge equipment and optimized for efficiency. National Dental Care – A series of high-end dental facilities developed in collaboration with industry leaders to enhance patient experience and operational effectiveness. Newarc Edge Fitouts prioritizes sustainability by using over 80% Australian-made products, reinforcing their commitment to local industry and environmental responsibility. With plans for international expansion, Mitesh and Josh continue to set new benchmarks for quality and innovation, solidifying Newarc Edge Fitouts' position as a leader in healthcare construction. Key Takeaways – By honing in on one industry, Newarc Edge delivers turnkey healthcare environments that tick every regulatory and ergonomic box—something a generalist fit-out firm typically can't match. – Their in-house medical/dental accreditation and award-winning craftsmanship give them a clear edge when doctors need a partner who 'gets' healthcare workflows. – General fit-out companies often win on cost flexibility and scale across sectors, but may lack the deep compliance know-how and specialist equipment networks that Newarc Edge brings. For more information, Newarc Edge Healthcare Construction Company. Author: Peter Sutherland TIME BUSINESS NEWS
Yahoo
19 hours ago
- Yahoo
Doctor mistakenly implants wrong embryo in IVF patient mix-up
One of Australia's top IVF providers mistakenly implanted a patient with her own embryo instead of her partner's. Monash IVF said the incident occurred on June 5 at a clinic in Melbourne but did not provide further details, such as how it learned of the bungle or what the couple planned to do next. The company said it was supporting the couple, who it did not identify. It marks the second fertility clinic mix-up of its kind in the country, heightening concerns about an industry that did not have much active government oversight until recently. The clinic said the patient's embryo was mistakenly implanted under a treatment plan which called for an embryo from the patient's partner to be transferred. The incident builds on a reputational maelstrom for Monash IVF, which was already reeling from an April disclosure that an Australian woman had given birth to a stranger's baby after a fertility doctor accidentally implanted the wrong embryo in Brisbane in 2023. That mix-up sparked concerns about security protocols at IVF clinics and an industry which is only now in the process of being more regulated. Monash claimed the world's first IVF pregnancy five decades ago and is Australia's second-largest IVF provider, carrying out nearly a quarter of the country's 100,000 assisted reproductive cycles a year, according to industry data. "This mix-up, the second reported incident at Monash IVF, risks shaking confidence not just in one provider but across the entire fertility sector," said Hilary Bowman-Smart, a researcher and bioethicist at the University of South Australia. Shares of Monash IVF were down 25 per cent by mid-session on Tuesday, against a rising broader market. The stock is just over half its value before the April announcement. "We had thought the Brisbane clinic embryo transfer error was an isolated incident," Craig Wong-Pan, an analyst at RBC Capital Markets, said in a client note. "We believe there is now risk of a greater impact of reputational damage and market share losses to MVF's operations." Monash IVF had already hired a lawyer to run an independent investigation after the Brisbane incident, and said on Tuesday it has extended the scope of that investigation. It added that it was installing interim extra verification safeguards to ensure patient confidence. It said it had reported the Melbourne incident to the Victorian Department of Health and industry licensing body, the Reproductive Technology Accreditation Committee (RTAC), part of industry group the Fertility Society of Australia. Victorian health minister Mary-Anne Thomas said the department was investigating the company and the incident. "Families should have confidence that the treatment they are receiving is done to the highest standard," she said. "It is clear Monash IVF has failed to deliver that, which is completely unacceptable." Fertility Society president Petra Wale said the incident would have had an emotional toll on the family, but stressed mistakes in the sector were rare. The society reiterated a call to implement nationally consistent laws around IVF. Currently, the country's IVF industry is regulated by a combination of industry bodies and state and territory health departments, resulting in a governance and compliance system that some groups say is too complex. Reports of transferring the wrong embryo are rare, according to fertility experts, and Monash's Brisbane mix-up was widely reported as the first known case of its kind.
